Imaging tau pathology in Parkinsonisms
Abstract The recent development of positron emission tomography radiotracers targeting pathological tau in vivo has led to numerous human trials. While investigations have primarily focused on the most common tauopathy, Alzheimer’s disease, it is imperative that testing also be performed in parkinso...
Enregistré dans:
Auteurs principaux: | Sarah Coakeley, Antonio P. Strafella |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6afea461ad4e4fbcb28d678c014008db |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
par: Paula Ramos-Gonzalez, et autres
Publié: (2021) -
Imaging Parkinson’s disease below the neck
par: Per Borghammer, et autres
Publié: (2017) -
Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
par: Chun Chen, et autres
Publié: (2021) -
Optimizing Parkinson’s disease diagnosis: the role of a dual nuclear imaging algorithm
par: J. William Langston, et autres
Publié: (2018) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
par: Moxin Wu, et autres
Publié: (2021)